These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Basal forebrain cholinergic immunolesion by 192IgG-saporin: evidence for a presynaptic location of subpopulations of alpha 2- and beta-adrenergic as well as 5-HT2A receptors on cortical cholinergic terminals. Heider M, Schliebs R, Rossner S, Bigl V. Neurochem Res; 1997 Aug; 22(8):957-66. PubMed ID: 9239751 [Abstract] [Full Text] [Related]
24. The effects of hypothyroidism on 5-HT1A and 5-HT2A receptors and the serotonin transporter protein in the rat brain. Kulikov AV, Jeanningro R. Neurosci Behav Physiol; 2001 Aug; 31(4):445-9. PubMed ID: 11508497 [Abstract] [Full Text] [Related]
25. 8-OH-DPAT influences extracellular levels of serotonin and dopamine in the medial preoptic area of male rats. Lorrain DS, Matuszewich L, Hull EM. Brain Res; 1998 Apr 20; 790(1-2):217-23. PubMed ID: 9593901 [Abstract] [Full Text] [Related]
27. Cerebral tryptophan hydroxylase activity, and 5-HT1A receptor, 5-HT2A receptor, and 5-HT transporter binding in grouped and isolated Roman RHA and RLA rats: relationships with behaviours in two models of anxiety. Kulikov A, Castanon N, Mormède P, Chaouloff F. Psychopharmacology (Berl); 1995 Oct 20; 121(3):385-95. PubMed ID: 8584622 [Abstract] [Full Text] [Related]
28. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? Jolas T, Schreiber R, Laporte AM, Chastanet M, De Vry J, Glaser T, Adrien J, Hamon M. J Pharmacol Exp Ther; 1995 Feb 20; 272(2):920-9. PubMed ID: 7853210 [Abstract] [Full Text] [Related]
30. Corticosterone regulation of serotonin transporter and 5-HT1A receptor expression in the aging brain. Maines LW, Keck BJ, Smith JE, Lakoski JM. Synapse; 1999 Apr 20; 32(1):58-66. PubMed ID: 10188639 [Abstract] [Full Text] [Related]
31. Overexpression of S100beta in transgenic mice does not protect from serotonergic denervation induced by 5,7-dihydroxytryptamine. Bendotti C, Cole SE, Gobbi M, Hohmann C, Reeves RH. J Neurosci Res; 2002 Feb 15; 67(4):501-10. PubMed ID: 11835317 [Abstract] [Full Text] [Related]
35. Binding of pinoline on the 5-hydroxytryptamine transporter: competitive interaction with [3H] citalopram. Pähkla R, Rägo L, Callaway JJ, Airaksinen MM. Pharmacol Toxicol; 1997 Mar 15; 80(3):122-6. PubMed ID: 9101584 [Abstract] [Full Text] [Related]
36. Differential effects of centrally-active antihypertensives on 5-HT1A receptors in rat dorso-lateral septum, rat hippocampus and guinea-pig hippocampus. Leishman DJ, Boeijinga PH, Galvan M. Br J Pharmacol; 1994 Jan 15; 111(1):318-24. PubMed ID: 8012713 [Abstract] [Full Text] [Related]
37. Enhancement of hippocampal cholinergic neurotransmission through 5-HT1A receptor-mediated pathways by repeated lithium treatment in rats. Fujii T, Nakai K, Nakajima Y, Kawashima K. Can J Physiol Pharmacol; 2000 May 15; 78(5):392-9. PubMed ID: 10841434 [Abstract] [Full Text] [Related]
38. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice. Li Q, Wichems C, Heils A, Van De Kar LD, Lesch KP, Murphy DL. J Pharmacol Exp Ther; 1999 Dec 15; 291(3):999-1007. PubMed ID: 10565817 [Abstract] [Full Text] [Related]
39. Region-specific decrease in 5-HT1A and 5-HT1B binding sites after intra-hippocampal ibotenic acid injections in the rat. Aït Amara D, Segu L, Buhot MC. Neurosci Lett; 2001 Sep 07; 310(1):25-8. PubMed ID: 11524149 [Abstract] [Full Text] [Related]
40. Effects of antipsychotic drugs on dopamine and serotonin contents and metabolites, dopamine and serotonin transporters, and serotonin1A receptors. Ase AR, Amdiss F, Hébert C, Huang N, van Gelder NM, Reader TA. J Neural Transm (Vienna); 1999 Sep 07; 106(1):75-105. PubMed ID: 10195336 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]